Everest Medicines Company
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Headquarters:
New York, New York, United States
Last Funding Type:
Series C
Investors Number:
10.0
Last Funding Date:
2020-06-03
Employee Number:
51-100
Total Funding:
310000000.0
Founded Date:
2017-01-01
Technology:
Biotechnology, Health Care, Pharmaceutical
Estimated Revenue:
$1M to $10M
Industry:
Clinical Development
Funding Status:
IPO